Should procalcitonin be used as a routine biomarker of bacterial infection?

Infection

Volumn 40, Issue 6, 2012, Pages 713-714

  Das, R R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN;

2009 H1N1 INFLUENZA; BACTERIAL INFECTION; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ERYTHROCYTE SEDIMENTATION RATE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LETTER; OUTCOME ASSESSMENT; UROSEPSIS; VIRUS PNEUMONIA;

BACTERIAL INFECTIONS; CALCITONIN; FEMALE; HUMANS; MALE; PROTEIN PRECURSORS; VIRUS DISEASES;

EID: 84874105905     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0253-6     Document Type: Letter

References (11)

1. Chalupa P, Beran O, Herwald H, Kaspříková N, Holub M. Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection. 2011;39:411-7.
2. Waterer GW, Rello J, Wunderink RG. Management of community-acquired pneumonia in adults. Am J Respir Crit Care Med. 2011;183:157-64.
3. Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol. 2010;48:2325-9.
4. Hammond NE, Corley A, Fraser JF. The utility of procalcitonin in diagnosis of H1N1 influenza in intensive care patients. Anaesth Intensive Care. 2011;39:238-41.
5. Cuquemelle E, Soulis F, Villers D, Roche-Campo F, Ara Somohano C, Fartoukh M, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med. 2011;37: 796-800.
6. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363:600-7.
7. Masiá M, Gutiérrez F, Padilla S, Soldán B, Mirete C, Shum C, et al. Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors. Clin Microbiol Infect. 2007;13:153-61.
8. Koeze J, Hendrix MG, van den Bergh FA, Brouwer RM, Zijlstra JG. In critically ill patients the procalcitonin level can be misleading. Crit Care. 2011;15:422.
9. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med. 2000;28:1828-32.
10. Ray P, Badarou-Acossi G, Viallon A, Boutoille D, Arthaud M, Trystram D, et al. Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear. Am J Emerg Med. 2007;25:179-84.
11. Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol. 2010;48:2325-9.